Abstract
To evaluate new drugs, the immune system should be considered. Here we evaluated a proof-of-concept that uncovers bacterial-leukocyte interactions. Analyzing longitudinal leukocyte data from bovines infected with either methicillin-resistant (MRSA) or methicillin-susceptible (MSSA) Staphylococcus aureus, two methods were investigated: (i) an approach that assesses lymphocytes, monocytes, or neutrophils, separately, and (ii) a method that, using dimensionless indicators (products, ratios, or combinations derived from leukocyte data), explores the dynamics of leukocyte relationships in three-dimensional (3D) space and identifies data subsets of informative value.
The classic approach not always distinguished infected from non-infected cows. In contrast, the alternative approach differentiated noninfected from infected animals and distinguished early MRSA from early MSSA and late MRSA infections.
Discrimination was associated with the use of dimensionless indicators. When measured in 3D space, such indicators generated a very large number of combinations, which helped detect data subsets usually unobserved, such as non-overlapping infection-negative and -positive subsets, and several disease stages. The validity of such data subsets was determined with biologically interpretable data.
This graphic, pattern recognition-based information system included but did not depend on any one number or variable. Because it can detect functions (relationships that involve two or more elements), in real time, if shown reproducible, the analysis of complex hostmicrobial dynamics could be used to evaluate antimicrobials.
Keywords: Infection, MRSA, MSSA, complexity, systems, dynamics, three-dimensional, cutoff-free discrimination.
Current Pharmaceutical Design
Title:Beyond Numbers: The Informative Patterns of Immuno-Staphylococcal Dynamics
Volume: 21 Issue: 16
Author(s): Ariel L. Rivas, Almira L. Hoogesteijn and Renata Piccinini
Affiliation:
Keywords: Infection, MRSA, MSSA, complexity, systems, dynamics, three-dimensional, cutoff-free discrimination.
Abstract: To evaluate new drugs, the immune system should be considered. Here we evaluated a proof-of-concept that uncovers bacterial-leukocyte interactions. Analyzing longitudinal leukocyte data from bovines infected with either methicillin-resistant (MRSA) or methicillin-susceptible (MSSA) Staphylococcus aureus, two methods were investigated: (i) an approach that assesses lymphocytes, monocytes, or neutrophils, separately, and (ii) a method that, using dimensionless indicators (products, ratios, or combinations derived from leukocyte data), explores the dynamics of leukocyte relationships in three-dimensional (3D) space and identifies data subsets of informative value.
The classic approach not always distinguished infected from non-infected cows. In contrast, the alternative approach differentiated noninfected from infected animals and distinguished early MRSA from early MSSA and late MRSA infections.
Discrimination was associated with the use of dimensionless indicators. When measured in 3D space, such indicators generated a very large number of combinations, which helped detect data subsets usually unobserved, such as non-overlapping infection-negative and -positive subsets, and several disease stages. The validity of such data subsets was determined with biologically interpretable data.
This graphic, pattern recognition-based information system included but did not depend on any one number or variable. Because it can detect functions (relationships that involve two or more elements), in real time, if shown reproducible, the analysis of complex hostmicrobial dynamics could be used to evaluate antimicrobials.
Export Options
About this article
Cite this article as:
L. Rivas Ariel, L. Hoogesteijn Almira and Piccinini Renata, Beyond Numbers: The Informative Patterns of Immuno-Staphylococcal Dynamics, Current Pharmaceutical Design 2015; 21 (16) . https://dx.doi.org/10.2174/1381612821666150310104053
DOI https://dx.doi.org/10.2174/1381612821666150310104053 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
3-Nitro-Tyrosine as an Internal Quencher of Autofluorescence Enhances the Compatibility of Fluorescence Based Screening of OBOC Combinatorial Libraries
Combinatorial Chemistry & High Throughput Screening 2,3-Dichloro-1,4-Naphthoquinone in Organic Synthesis: Recent Advances
Mini-Reviews in Organic Chemistry Molecular Imaging Aided Improvement in Drug Discovery and Development
Current Biotechnology Colloidal Supramolecular Aggregates for Therapeutic Application in Neuromedicine
Current Medicinal Chemistry Meet our Editorial Board Member
Current Cancer Therapy Reviews Targeting Inhibition of COX-2: A Review of Patents, 2002 - 2006
Recent Patents on Inflammation & Allergy Drug Discovery Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases
Current Medicinal Chemistry Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment
Current Pharmaceutical Design Identification of KEY lncRNAs and mRNAs Associated with Oral Squamous Cell Carcinoma Progression
Current Bioinformatics Radiosensitization of Prostate Cancer by Soy Isoflavones
Current Cancer Drug Targets Rapid Nucleic Acid Reaction Circuits for Point-of-care Diagnosis of Diseases
Current Topics in Medicinal Chemistry Pharmacogenetics of Irinotecan
Current Medicinal Chemistry - Anti-Cancer Agents A Glimpse of Matrix Metalloproteinases in Diabetic Nephropathy
Current Medicinal Chemistry The Significant Role of Nutraceutical Compounds in Ulcerative Colitis Treatment
Current Medicinal Chemistry Understanding Membrane Protein Drug Targets in Computational Perspective
Current Drug Targets Ultrasensitive Electrochemical Sensors for PSA Detection: Related Surface Functionalization Strategies
Current Topics in Medicinal Chemistry Aptamers in Targeted Nanotherapy
Current Topics in Medicinal Chemistry <i>Drosophila melanogaster</i> a Versatile Model of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Nitric Oxide Induced Damage and Preventive Effect of Curcumin and Quercetin on Buffalo Brain Cystatin
Current Proteomics Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis
Current Pharmaceutical Biotechnology